Haemophilia Foundation Australia logo HAEMOPHILIA FOUNDATION A.C.T. ACT Floral Emblem - Royal Bluebell - ©Australian National Botanic Gardens, used with permission
Overview
Newsletters
Links
This Newsletter

HFACT Newsletter June/July 2006
HAEMOPHILIA FOUNDATION
AUSTRALIAN CAPITAL TERRITORY
INCORPORATED
 
  GPO Box 936 Canberra City ACT 2601

NEWSLETTER

       

Improved supply security and more choice for recombinant products

     

The following statement is an extract from a media release on 18 May 2006 by the National Blood Authority:

The National Blood Authority (NBA) has signed new contracts for the supply of recombinant and certain plasma products which will take effect from 1 July 2006.

These contracts provide products which are not produced in Australia, but are needed to provide the best quality of care for people with haemophilia and other bleeding disorders.

Under the new arrangements two additional recombinant products will be available to treat Haemophilia A, providing not only choice of product for patients, but greatly enhancing supply security for Australia. “These new contractual arrangements ensure the supply of the world’s best products for Australian patients,” said Dr Alison Turner, General Manager, NBA.

Three supplier will now provide a range of products in Australia. These are: Baxter Healthcare Australia Pty Ltd, Novo Nordisk Pharmaceuticals Pty Ltd and Wyeth Australia Pty Ltd.

   

The new contracts require the suppliers to make various performance guarantees to ensure that product is available when and where needed.

I understand that plans are underway to provide information sessions for patients and treatment providers over the next six months or so. The sessions will provide information about the range of products available and help with making choices about treatment.

I will keep you informed of any sessions that planned for the ACT.

Full text of the media release and further details concerning this important development are available from the NBA Website:

National Blood Authority www.nba.gov.au

Fred (President)


       

What does it take?

     

What does it take to change things?
  What does it take to make things better?
    What is the haemophilia foundation anyway?

ANSWER:
You, and your involvement!. The haemophilia foundation consists of you, and others like you, who share a common interest, problems or issues associated with haemophilia.

Things will only happen if you and others in the group participate, go to the functions, even

   

join the committee! The opportunity for involvement is always there!

Do you have a skill or talent to offer? Are you simply prepared to help? If so then you should consider joining the committee!

The opportunity to do this comes around again at the Annual General Meeting which will be held in the next few months. Contact Fred or one of the other committee members to find out more.

       

 Top of page

- 2 -

First report from the World Federation Congress

     

Due to generous financial assistance from HFA and HFACT, I was recently able to attend the XXVII International Congress of the World Federation of Haemophilia held in Vancouver in May.

Vancouver is a spectacularly beautiful city, bordered to the north by snow-clad mountains, to the west by the Pacific Ocean and to the south by the USA. With a population of just over 2 million it is the largest city in British Columbia, and the third largest city in Canada. It enjoys a mild climate with temperatures rarely going above 25 in Summer or below 5 in Winter. The only drawback is the rain, of which we copped our share, but the lushness of the gardens compensated for that. It’s obviously the perfect weather for rhododendrons as they were in flower everywhere I looked. I found the Canadians to be friendly and relaxed, and with daylight lasting until 10pm and most shops open until 9pm every day, it was great to just wander the streets in the evening and enjoy the atmosphere.

The conference was held at the Vancouver Exhibition and Convention Centre which is located right on the waterfront in downtown Vancouver, and was attended by 4000 delegates from over 100 countries.

Vancouver Conference and Exhibition centre
View of the Vancouver Conference and Exhibition centre on the waterfront (the site of the World Federation Congress)

The first day was divided into workshops for the various profession groups, and nurses had the choice of attending either beginning or advanced programmes. I chose the advanced programme, which covered some very interesting topics. Two UK nurses spoke about the development of nurse-led haemophilia clinics, with one describing the course she had completed which enabled her to prescribe medications and the impact of that on haemophilia care. Other topics covered included an overview of rare bleeding disorders (including a case-study of a patient with factor XIII deficiency), severe haemophilia and ageing, acquired haemophilia, and an unusual case history of a family with both factor VIII and factor IX deficiency. Educating young people with bleeding disorders about nutrition, exercise and sport was also discussed with the worrying increase in childhood obesity.

   

That evening we were officially welcomed to the conference and Vancouver and were entertained by a Scottish Highland band and native North American dancing. The conference began in earnest the following day consisting of four full days of meetings, with topics

of interest to doctors, nurses, counsellors, physios, dentists and scientists working in the field of haemophilia, as well as to people with haemophilia.

The theme of this year’s conference was “Treatment for all; a vision for the future”. Mark Skinner, the president of the World Federation of Haemophilia spoke passionately about WFH’s new strategic plan, which embraces the vision of treatment for all, regardless of where they live in the world. Currently 75% of people with bleeding disorders worldwide receive either inadequate or no treatment, WFH’s mission is to improve treatment where it is limited or non-existent, while sustaining the many gains that have already been made. These include proper diagnosis, management and care by a multi-disciplined team of trained specialists; and expanding services beyond haemophilia to those with Von Willebrand’s Disease, rare factor deficiencies and inherited platelet disorders.

The conference contained many highlights, including the opportunity to meet other haemophilia nurses and learn more about how things are done in larger centres. One session of particular interest to me dealt with the transition of adolescents from paediatric to adult care. An American nurse described an education programme she had put together to facilitate the process of adolescent boys taking more responsibility for their treatment and health. The programme encouraged the boys to be thinking about suitable sport and career choices, girlfriends and genetic counselling issues as well as taking responsibility for practical things like ordering their own factor and supplies. There were some really good ideas raised, and I plan to modify the programme for our own boys in the ACT.

In conclusion, the XXVII International Congress of the World Federation of Haemophilia was a wonderful educational and social event and my sincere thanks go to the HFA and HFACT for enabling me to attend.

Liz Jarvis
(Haemophilia Nurse, ACT)


NOTE.
Other persons from HFACT also attended the World Federation congress in Vancouver. More photos and reports will be included in the next newsletter.


       

 Top of page

- 3 -

The Oxford Factor

     

As advertised in the previous newsletter, Dr Pidcock shared his experiences in Oxford with the group at a meeting held at the Wensing residence in April.

Dr Pidcock spent six months on sabbatical in Oxford in 2005, located at the Oxford Haemophilia Centre and Thrombosis Research Unit, Churchill Hospital two miles East of the Oxford city centre.

Oxford Haemophilia Centre
Dr Pidcock outside the Oxford Haemophilia Centre

The Centre is one of 22 Comprehensive Care Centres in the United Kingdom, and provides regular treatment for approximately 250 people with bleeding disorders each year.

The centre was involved in the early developments of fractionated products.

The Centre was the first clinical facility devoted to the care of people with bleeding disorders to be founded in the United Kingdom. During the 1950s pioneering research work in the area of blood coagulation was carried out in Oxford by Professor Gwyn Macfarlane and Rosemary Biggs in the Blood Coagulation Research Unit. Haemophilia B was first identified there, and takes its alternative name of Christmas disease from the surname of the young patient studied in 1952.

Following the retirement of Professor Macfarlane, a Haemophilia Centre was opened on the site of the former research laboratory in 1968.

   

Coagulation factor concentrates were made in the Plasma Fractionation Laboratory between 1968 and 1992. As well as concentrates of factor VIII and IX, factor VII, XI, plasma-derived factor XIII and porcine factor VIII were made there.

No other centre in the UK treats more patients with haemophilia.

The Oxford Haemophilia Centre was designated an International Haemophilia Training Centre by the World Federation of Haemophilia in 1974.

Given the credentials of this centre, it has been good that Dr Pidcock could spend some time there.

While placed at the Oxford Haemophilia Centre, Dr Pidcock carried out some research into the use of a machine that tests for platelet function to see whether it could be used to detect the effects of anti-platelet drugs. The results of this research were positive and a paper has been accepted for publication in the Journal of Thrombosis and Haemostasis.

After his time away, Dr Pidcock has returned to Canberra refreshed and ready to continue to face the challenges of local haemophilia care (and other responsibilities too numerous to mention).


Liz, Stephen, Chris and Clare have a cup of tea and chat to Dr Pidcock after listening to his presentation

       

 Top of page

- 4 -

New support group for people living with Hepatitis C

     

The ACT Hepatitis C Council is launching a new information and support group for people living with Hepatitis C.

The first meeting will be held on Thursday 20th July at 4.00pm at Suite 1, 15 Sargood Street, O'Connor ACT 2602.

Clinical nurse specialist Anne Blunn, who runs the Hepatitis C clinic at Canberra Hospital, will give a talk on 'treatment options for people with Hepatitis C' and will answer any questions you may have.

Even if you have decided against treatment, come along for the discussion and support. Because of the stigma associated with Hepatitis C, it can be difficult to be open about it, particularly if you don't know anyone else with Hep C.

   

The public perception is that it is a disease associated with illegal drug use, a view that ignores the sizeable minority who acquired the illness in other ways. Sharing ideas and information with others who understand what it's like can provide valuable emotional support.

Depending on demand, future meetings may include talks on 'the role of nutrition in alleviating symptoms' and 'Traditional Chinese Medicine - can it help?'

Liver-friendly snacks and teas will be provided.

Please confirm your attendance by either email to:

    marie.acthepccouncil@gmail.com

or by phone or text message to 0422 526 008.


       

Message from Clare

     

Last year many of the haemophilia community in Canberra participated in a Quality of Life Survey conducted by Dr Dipti Talaulikar.

Following on from the survey, Dr Michael Pidcock, Dr Dipti Talaulikar, Liz Jarvis and myself recognised the need for the availability of psychological services from time to time for people with haemophilia.

Further discussion with Dr Dipti Talaulikar, Dr Kerry Leahan from the Psychology Department at the Canberra Hospital and myself has formulated a service availability and referral system.

   

The Psychology Department will accept referrals from TCH haematologists, Liz Jarvis or myself. There will be no cost for this service.

I would also like to let you know that I will be on annual leave for the month of August - heading North to the warmth.

Warmest regards to you all,

Clare Reeves
(Haemophilia Counsellor)

     
 

Acknowledgment

The Haemophilia Foundation ACT would like to acknowledge that our newsletter has been partly funded through funds provided by ACT Health.


 

 Contact: Secretary@hfact.org.au
Top of document

Last updated: 7 March 2010